Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

10680	Companies
228001	Keywords
156512	Articles
120874	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

PRESS RELEASE

published on 04/29/2026 at 00:00, 2 months 5 days ago

Onco-Innovations Announces Successful Scale-Up of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for its PNKP Inhibitor Technology Program
Onco-Innovations successfully scales up key intermediates A83 and B4, advancing its CMC program for nanoparticle-based PNKP inhibitor drug ONC010. Collaborates with Dalton Pharma Services for process optimization and future GMP manufacturing

Scale-up Onco-Innovations Dalton Pharma Services Intermediates CMC Program
BRIEF

published on 04/24/2026 at 00:05, 2 months 10 days ago

Onco-Innovations Enhances Polymer Testing for PNKP Inhibitor Development

Onco-Innovations PNKP Inhibitor Polymer Testing Clinical Manufacturing RI-GPC
BRIEF

published on 04/24/2026 at 00:05, 2 months 10 days ago

Onco-Innovations améliore les tests de polymères pour le développement d'inhibiteurs de PNKP

Onco-Innovations Inhibiteur De PNKP RI-GPC Tests De Polymères Fabrication Clinique
PRESS RELEASE

published on 04/24/2026 at 00:00, 2 months 10 days ago

Onco-Innovations Advances Polymer Testing as It Moves Its PNKP Inhibitor Technology Toward IND-Enabling Studies
Onco-Innovations Limited announces advancement in analytical method for PNKP Inhibitor Technology, strengthening formulation development and scale-up for clinical manufacturing

Onco-Innovations Limited PNKP Inhibitor Technology Analytical Method Clinical Manufacturing Formulation Development
BRIEF

published on 04/22/2026 at 00:05, 2 months 12 days ago

Onco-Innovations Completes Key Method Development for ONC010 Program

Drug Development Quality Control Onco-Innovations Analytical Method Purity Determination
BRIEF

published on 04/22/2026 at 00:05, 2 months 12 days ago

Onco-Innovations finalise le développement d'une méthode clé pour le programme ONC010

Contrôle De Qualité Développement De Médicaments Onco-Innovations Méthode Analytique Détermination De La Pureté
PRESS RELEASE

published on 04/22/2026 at 00:00, 2 months 12 days ago

Onco-Innovations Announces Completion of Analytical Method Development for Monomer Intermediate 1 Supporting ONC010 Program
Onco-Innovations successfully completes milestone with Dalton Pharma Services, developing analytical method for purity determination of Intermediate 1 supporting ONC010, enhancing drug delivery system quality control

Quality Control Drug Delivery System Onco-Innovations Dalton Pharma Services Analytical Method Development
BRIEF

published on 04/18/2026 at 01:05, 2 months 16 days ago

Onco-Innovations renforce son équipe dirigeante grâce à des nominations clés

Essais Cliniques Leadership En Biotechnologie Développement En Oncologie Nominations De Cadres Supérieurs Stratégie De Recherche
BRIEF

published on 04/18/2026 at 01:05, 2 months 16 days ago

Onco-Innovations Enhances Leadership with Key Appointments

Clinical Trials Executive Appointments Oncology Development Research Strategy Leadership In Biotechnology
PRESS RELEASE

published on 04/18/2026 at 01:00, 2 months 16 days ago

Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
Onco-Innovations appoints Dr. Islam Mohamed as CMO and Stephen M. Novak as Chief of R&D, aiming to enhance clinical and development capabilities for advancing ONC010. Strategic leadership additions for Onco's transition to clinical-stage execution

Appointment Clinical Development R&D Onco-Innovations ONC010

Accesswire

Published on 07/03/2026 at 23:00, 16 hours 36 minutes ago

Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 23:00, 16 hours 36 minutes ago

Medicure Announces CFO Change
Published on 07/03/2026 at 21:28, 18 hours 8 minutes ago

Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 20 hours 6 minutes ago

Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 1 day 2 hours ago

Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation

View all ACCESSWIRE

EQS Group

Published on 07/04/2026 at 11:01, 4 hours 34 minutes ago

EQS-Adhoc: Continental AG: Continental AG Sells ContiTech Group Sector
Published on 07/04/2026 at 09:05, 6 hours 30 minutes ago

Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love
Published on 07/03/2026 at 19:00, 20 hours 35 minutes ago

PATRIMOINE ET COMMERCE: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE AU 30 JUIN 2026
Published on 07/03/2026 at 18:55, 20 hours 40 minutes ago

Saudia Arabia's Mabani Aljazeera Group invests in Tatu City's Jabali Towers development
Published on 07/03/2026 at 18:14, 21 hours 21 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 07/03/2026 at 21:49, 17 hours 46 minutes ago

Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 17 hours 46 minutes ago

Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 20 hours 53 minutes ago

Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:42, 20 hours 53 minutes ago

Capital et droits de vote au 30 juin 2026
Published on 07/03/2026 at 18:36, 20 hours 59 minutes ago

Disclosure of transactions in own shares from July 1 to July 3, 2026

View all LES ECHOS COMFI WIRE